DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Fundamental Analysis & Valuation

FRA:DBAN • DE000A1TNUT7

Current stock price

25.75 EUR
+0.3 (+1.18%)
Last:

This DBAN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DBAN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year DBAN was profitable.
  • DBAN had a positive operating cash flow in the past year.
  • Of the past 5 years DBAN 4 years were profitable.
  • DBAN had a positive operating cash flow in 4 of the past 5 years.
DBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFDBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • DBAN has a Return On Assets of 2.68%. This is in the better half of the industry: DBAN outperforms 65.25% of its industry peers.
  • DBAN's Return On Equity of 3.86% is in line compared to the rest of the industry. DBAN outperforms 46.61% of its industry peers.
  • DBAN's Return On Invested Capital of 1.34% is in line compared to the rest of the industry. DBAN outperforms 50.85% of its industry peers.
  • DBAN had an Average Return On Invested Capital over the past 3 years of 5.70%. This is below the industry average of 8.97%.
  • The 3 year average ROIC (5.70%) for DBAN is well above the current ROIC(1.34%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.68%
ROE 3.86%
ROIC 1.34%
ROA(3y)7.6%
ROA(5y)6.58%
ROE(3y)8.86%
ROE(5y)7.24%
ROIC(3y)5.7%
ROIC(5y)N/A
DBAN.DE Yearly ROA, ROE, ROICDBAN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • DBAN's Profit Margin of 31.14% is amongst the best of the industry. DBAN outperforms 81.36% of its industry peers.
  • DBAN's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.71%, DBAN is in the better half of the industry, outperforming 60.17% of the companies in the same industry.
  • DBAN's Operating Margin has declined in the last couple of years.
  • DBAN's Gross Margin of 86.89% is amongst the best of the industry. DBAN outperforms 88.98% of its industry peers.
  • DBAN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.71%
PM (TTM) 31.14%
GM 86.89%
OM growth 3Y-45.59%
OM growth 5YN/A
PM growth 3Y-43.76%
PM growth 5YN/A
GM growth 3Y-5.04%
GM growth 5Y-1.59%
DBAN.DE Yearly Profit, Operating, Gross MarginsDBAN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DBAN.DE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, DBAN has less shares outstanding
  • Compared to 5 years ago, DBAN has more shares outstanding
  • Compared to 1 year ago, DBAN has a worse debt to assets ratio.
DBAN.DE Yearly Shares OutstandingDBAN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
DBAN.DE Yearly Total Debt VS Total AssetsDBAN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • DBAN has an Altman-Z score of 1.66. This is a bad value and indicates that DBAN is not financially healthy and even has some risk of bankruptcy.
  • DBAN's Altman-Z score of 1.66 is fine compared to the rest of the industry. DBAN outperforms 64.41% of its industry peers.
  • DBAN has a debt to FCF ratio of 6.72. This is a slightly negative value and a sign of low solvency as DBAN would need 6.72 years to pay back of all of its debts.
  • The Debt to FCF ratio of DBAN (6.72) is better than 65.25% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that DBAN is not too dependend on debt financing.
  • DBAN has a better Debt to Equity ratio (0.21) than 72.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 6.72
Altman-Z 1.66
ROIC/WACCN/A
WACCN/A
DBAN.DE Yearly LT Debt VS Equity VS FCFDBAN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • DBAN has a Current Ratio of 0.92. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DBAN has a Current ratio (0.92) which is comparable to the rest of the industry.
  • DBAN has a Quick Ratio of 0.92. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.92, DBAN is in line with its industry, outperforming 55.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
DBAN.DE Yearly Current Assets VS Current LiabilitesDBAN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DBAN.DE Growth Analysis

3.1 Past

  • DBAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.11%.
  • The Revenue for DBAN has decreased by -45.29% in the past year. This is quite bad
  • DBAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 44.84% yearly.
EPS 1Y (TTM)-64.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.09%
Revenue 1Y (TTM)-45.29%
Revenue growth 3YN/A
Revenue growth 5Y44.84%
Sales Q2Q%-41.79%

3.2 Future

  • Based on estimates for the next years, DBAN will show a very strong growth in Earnings Per Share. The EPS will grow by 28.37% on average per year.
  • Based on estimates for the next years, DBAN will show a small growth in Revenue. The Revenue will grow by 1.59% on average per year.
EPS Next Y65.12%
EPS Next 2Y40.72%
EPS Next 3Y28.37%
EPS Next 5YN/A
Revenue Next Year-10.22%
Revenue Next 2Y0.68%
Revenue Next 3Y1.59%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DBAN.DE Yearly Revenue VS EstimatesDBAN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 50M -50M 100M 150M 200M
DBAN.DE Yearly EPS VS EstimatesDBAN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5

More info and screens

Find the best growth stocksShow best growing peers

6

4. DBAN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.07 indicates a rather expensive valuation of DBAN.
  • DBAN's Price/Earnings ratio is a bit cheaper when compared to the industry. DBAN is cheaper than 66.10% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of DBAN to the average of the S&P500 Index (27.95), we can say DBAN is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 10.39, which indicates a very decent valuation of DBAN.
  • 89.83% of the companies in the same industry are more expensive than DBAN, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of DBAN to the average of the S&P500 Index (38.68), we can say DBAN is valued rather cheaply.
Industry RankSector Rank
PE 19.07
Fwd PE 10.39
DBAN.DE Price Earnings VS Forward Price EarningsDBAN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.98% of the companies in the same industry are more expensive than DBAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.13
EV/EBITDA N/A
DBAN.DE Per share dataDBAN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DBAN's earnings are expected to grow with 28.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y40.72%
EPS Next 3Y28.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. DBAN.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.93%, DBAN has a reasonable but not impressive dividend return.
  • DBAN's Dividend Yield is a higher than the industry average which is at 3.01.
  • DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

  • The dividend of DBAN decreases each year by -2.48%.
Dividend Growth(5Y)-2.48%
Div Incr Years0
Div Non Decr Years3
DBAN.DE Yearly Dividends per shareDBAN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 90.09% of the earnings are spent on dividend by DBAN. This is not a sustainable payout ratio.
DP90.09%
EPS Next 2Y40.72%
EPS Next 3Y28.37%
DBAN.DE Yearly Income VS Free CF VS DividendDBAN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
DBAN.DE Dividend Payout.DBAN.DE Dividend Payout, showing the Payout Ratio.DBAN.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DBAN.DE Fundamentals: All Metrics, Ratios and Statistics

DEUTSCHE BETEILIGUNGS AG

FRA:DBAN (4/21/2026, 5:08:12 PM)

25.75

+0.3 (+1.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners11.03%
Inst Owner ChangeN/A
Ins Owners38.61%
Ins Owner ChangeN/A
Market Cap484.10M
Revenue(TTM)79.30M
Net Income(TTM)24.70M
Analysts86.15
Price Target34.1 (32.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend1.25
Dividend Growth(5Y)-2.48%
DP90.09%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.35%
PT rev (3m)-8.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)23.14%
EPS NY rev (3m)23.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)-20.04%
Valuation
Industry RankSector Rank
PE 19.07
Fwd PE 10.39
P/S 6.1
P/FCF 14.13
P/OCF 13.83
P/B 0.76
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)1.35
EY5.24%
EPS(NY)2.48
Fwd EY9.63%
FCF(TTM)1.82
FCFY7.08%
OCF(TTM)1.86
OCFY7.23%
SpS4.22
BVpS34.02
TBVpS33.34
PEG (NY)0.29
PEG (5Y)N/A
Graham Number32.1482 (24.85%)
Profitability
Industry RankSector Rank
ROA 2.68%
ROE 3.86%
ROCE 1.9%
ROIC 1.34%
ROICexc 1.57%
ROICexgc 1.61%
OM 18.71%
PM (TTM) 31.14%
GM 86.89%
FCFM 43.2%
ROA(3y)7.6%
ROA(5y)6.58%
ROE(3y)8.86%
ROE(5y)7.24%
ROIC(3y)5.7%
ROIC(5y)N/A
ROICexc(3y)6.33%
ROICexc(5y)N/A
ROICexgc(3y)6.48%
ROICexgc(5y)N/A
ROCE(3y)8.09%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-45.59%
OM growth 5YN/A
PM growth 3Y-43.76%
PM growth 5YN/A
GM growth 3Y-5.04%
GM growth 5Y-1.59%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 6.72
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.93%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 138.72%
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 1.66
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.69%
Cap/Sales(5y)0.74%
Profit Quality(3y)57.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.09%
EPS Next Y65.12%
EPS Next 2Y40.72%
EPS Next 3Y28.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-45.29%
Revenue growth 3YN/A
Revenue growth 5Y44.84%
Sales Q2Q%-41.79%
Revenue Next Year-10.22%
Revenue Next 2Y0.68%
Revenue Next 3Y1.59%
Revenue Next 5YN/A
EBIT growth 1Y-81.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.31%
EBIT Next 3Y16.3%
EBIT Next 5YN/A
FCF growth 1Y177.87%
FCF growth 3Y6.14%
FCF growth 5YN/A
OCF growth 1Y168.31%
OCF growth 3Y5.82%
OCF growth 5YN/A

DEUTSCHE BETEILIGUNGS AG / DBAN.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DBAN.DE.


What is the valuation status for DBAN stock?

ChartMill assigns a valuation rating of 6 / 10 to DEUTSCHE BETEILIGUNGS AG (DBAN.DE). This can be considered as Fairly Valued.


How profitable is DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

DEUTSCHE BETEILIGUNGS AG (DBAN.DE) has a profitability rating of 5 / 10.


What is the valuation of DEUTSCHE BETEILIGUNGS AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 19.07 and the Price/Book (PB) ratio is 0.76.


What is the financial health of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

The financial health rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 3 / 10.